These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8570267)

  • 1. New World tegumentar leishmaniasis: chemotherapeutic activity of rifampicin in humans and experimental murine model.
    Do Valle TZ; Oliveira Neto MP; Schubach A; Lagrange PH; Da Costa SC
    Pathol Biol (Paris); 1995 Sep; 43(7):618-21. PubMed ID: 8570267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Gonçalves GS; Fernandes AP; Souza RC; Cardoso JE; de Oliveira-Silva F; Maciel FC; Rabello A; Ferreira LA
    Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania (V.) braziliensis: detection by PCR in biopsies from patients with cutaneous leishmaniasis.
    Gomes AH; Armelin IM; Menon SZ; Pereira-Chioccola VL
    Exp Parasitol; 2008 Jul; 119(3):319-24. PubMed ID: 18442815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis.
    Sousa AQ; Frutuoso MS; Moraes EA; Pearson RD; Pompeu MM
    Clin Infect Dis; 2011 Oct; 53(7):693-5. PubMed ID: 21890773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
    Brown M; Noursadeghi M; Boyle J; Davidson RN
    Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different isolates from Leishmania braziliensis complex induce distinct histopathological features in a murine model of infection.
    Pereira CG; Silva AL; de Castilhos P; Mastrantonio EC; Souza RA; Romão RP; Rezende RJ; Pena JD; Beletti ME; Souza MA
    Vet Parasitol; 2009 Nov; 165(3-4):231-40. PubMed ID: 19656631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
    Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
    Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
    Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F
    Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil.
    Tojal da Silva AC; Cupolillo E; Volpini AC; Almeida R; Romero GA
    Trop Med Int Health; 2006 Sep; 11(9):1388-98. PubMed ID: 16930261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer.
    Machado P; Araújo C; Da Silva AT; Almeida RP; D'Oliveira Jr A; Bittencourt A; Carvalho EM
    Clin Infect Dis; 2002 Jun; 34(12):E69-73. PubMed ID: 12032913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Roblot F; Cavé A
    Planta Med; 1994 Feb; 60(1):8-12. PubMed ID: 8134421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate.
    Donnelly KB; Lima HC; Titus RG
    J Parasitol; 1998 Feb; 84(1):97-103. PubMed ID: 9488345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate.
    Rodriguez N; Bailey BN; Martin MB; Oldfield E; Urbina JA; Docampo R
    J Infect Dis; 2002 Jul; 186(1):138-40. PubMed ID: 12089677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.
    Vieira-Gonçalves R; Pirmez C; Jorge ME; Souza WJ; Oliveira MP; Rutowitsch MS; Da-Cruz AM
    Int J Dermatol; 2008 Sep; 47(9):926-32. PubMed ID: 18937655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome.
    Rosatelli JB; Souza CS; Soares FA; Foss NT; Roselino AM
    J Eur Acad Dermatol Venereol; 1998 May; 10(3):229-32. PubMed ID: 9643326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach.
    Romero GA; Vinitius De Farias Guerra M; Gomes Paes M; de Oliveira Macêdo V
    Clin Infect Dis; 2001 May; 32(9):1304-12. PubMed ID: 11303265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.